dpp4 and glp 1 mechanism of action Inhibitors vs GLP-1 Agonists | June 2021 | Clinical Corner The pharmacology of DPP-4 inhibitors

Select the intended configuration before adding this material to the cart

Leafy greens, such as spinach, kale, and arugula, are packed with micronutrients and are low in calories

Of note, even before the introduction of the newer classes of medications, multifactorial, target-driven therapies addressing glycaemic, blood pressure and lipid control that incorporated reninangiotensin system blockade, the use of statins and attention to lifestyle factors significantly reduced the progression to end-stage kidney disease by about 50% in people with type 2 diabetes, hypertension and microalbuminuria

For comparisons involving more than two groups, one-way analysis of variance (ANOVA) was applied to normally distributed data, followed by Bonferronis post-hoc correction to control for multiple comparisons